HBW
ANGO icon

Hazlett, Burt & Watson’s AngioDynamics ANGO Stock Holding History

Hazlett, Burt & Watson’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Hold
157
– – ﹤0.01% 835
2026
Q1 		$2K Hold
157
– – ﹤0.01% 844
2025
Q4 		$2K Hold
157
– – ﹤0.01% 853
2025
Q3 		$2K Buy
+157
New +$1.51K ﹤0.01% 802

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hazlett, Burt & Watson's ANGO Position: Q2 2026 in Review

Hazlett, Burt & Watson held its AngioDynamics (ANGO) position steady in Q2 2026 at 157 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Hazlett, Burt & Watson first reported a position in ANGO in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Hazlett, Burt & Watson held 157 shares of AngioDynamics worth $2K as of Q2 2026.
  • Hazlett, Burt & Watson left its AngioDynamics share count unchanged in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #835 holding.
  • Hazlett, Burt & Watson first reported a position in AngioDynamics in Q3 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.